Literature DB >> 15596830

Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.

Ziying Yan1, Roman Zak, Yulong Zhang, John F Engelhardt.   

Abstract

The relatively small package capacity (less than 5 kb) of adeno-associated virus (AAV) vectors has been effectively doubled with the development of dual-vector heterodimerization approaches. However, the efficiency of such dual-vector systems is limited not only by the extent to which intermolecular recombination occurs between two independent vector genomes, but also by the directional bias required for successful transgene reconstitution following concatemerization. In the present study, we sought to evaluate the mechanisms by which inverted terminal repeat (ITR) sequences mediate intermolecular recombination of AAV genomes, with the goal of engineering more efficient vectors for dual-vector trans-splicing approaches. To this end, we generated a novel AAV hybrid-ITR vector characterized by an AAV-2 and an AAV-5 ITR at opposite ends of the viral genome. This hybrid genome was efficiently packaged into either AAV-2 or AAV-5 capsids to generate infectious virions. Hybrid AV2:5 ITR viruses had a significantly lower capacity to form circular intermediates in infected cells than homologous AV2:2 and AV5:5 ITR vectors despite their similar capacity to express an encoded enhanced green fluorescent protein (EGFP) transgene. To examine whether the divergent ITR sequences contained within hybrid AV2:5 ITR vectors could direct intermolecular recombination in a tail-to-head fashion, we generated two hybrid ITR trans-splicing vectors (AV5:2LacZdonor and AV2:5LacZacceptor). Each delivered one exon of a beta-galactosidase minigene flanked by donor or acceptor splice sequences. These hybrid trans-splicing vectors were compared to homologous AV5:5 and AV2:2 trans-splicing vector sets for their ability to reconstitute beta-galactosidase gene expression. Results from this comparison demonstrated that hybrid ITR dual-vector sets had a significantly enhanced trans-splicing efficiency (6- to 10-fold, depending on the capsid serotype) compared to homologous ITR vectors. Molecular studies of viral genome structures suggest that hybrid ITR vectors provide more efficient directional recombination due to an increased abundance of linear-form genomes. These studies provide direct evidence for the importance of ITR sequences in directing intermolecular and intramolecular homologous recombination of AAV genomes. The use of hybrid ITR AAV vector genomes provides new strategies to manipulate viral genome conversion products and to direct intermolecular recombination events required for efficient dual-AAV vector reconstitution of the transgene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596830      PMCID: PMC538689          DOI: 10.1128/JVI.79.1.364-379.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization.

Authors:  L Sun; J Li; X Xiao
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

2.  A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation.

Authors:  D Duan; Y Yue; Z Yan; J F Engelhardt
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

3.  Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.

Authors:  Z Yan; Y Zhang; D Duan; J F Engelhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation.

Authors:  S Sanlioglu; P Benson; J F Engelhardt
Journal:  Virology       Date:  2000-03-01       Impact factor: 3.616

5.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

Authors:  M A Kay; C S Manno; M V Ragni; P J Larson; L B Couto; A McClelland; B Glader; A J Chew; S J Tai; R W Herzog; V Arruda; F Johnson; C Scallan; E Skarsgard; A W Flake; K A High
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

6.  Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

Review 7.  Adeno-associated viral vectors as gene delivery vehicles.

Authors:  P J Carter; R J Samulski
Journal:  Int J Mol Med       Date:  2000-07       Impact factor: 4.101

8.  Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.

Authors:  J A Wagner; A H Messner; M L Moran; R Daifuku; K Kouyama; J K Desch; S Manley; A M Norbash; C K Conrad; S Friborg; T Reynolds; W B Guggino; R B Moss; B J Carter; J J Wine; T R Flotte; P Gardner
Journal:  Laryngoscope       Date:  1999-02       Impact factor: 3.325

9.  Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

Authors:  D Duan; Y Yue; Z Yan; J Yang; J F Engelhardt
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

10.  Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter.

Authors:  J N Hagstrom; L B Couto; C Scallan; M Burton; M L McCleland; P A Fields; V R Arruda; R W Herzog; K A High
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

View more
  43 in total

1.  Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes.

Authors:  Marcela P Cataldi; Douglas M McCarty
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo.

Authors:  Ziying Yan; Diana C M Lei-Butters; Yulong Zhang; Roman Zak; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2007-01       Impact factor: 5.695

3.  Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors.

Authors:  Yi Lai; Yongping Yue; Mingju Liu; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2006-10       Impact factor: 5.695

4.  Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.

Authors:  Jinhui Wang; Jing Xie; Hui Lu; Lingxia Chen; Bernd Hauck; Richard Jude Samulski; Weidong Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

5.  AAV5-mediated gene transfer to the parotid glands of non-human primates.

Authors:  A Voutetakis; C Zheng; A P Cotrim; F Mineshiba; S Afione; N Roescher; W D Swaim; M Metzger; M A Eckhaus; R E Donahue; C E Dunbar; J A Chiorini; B J Baum
Journal:  Gene Ther       Date:  2009-09-17       Impact factor: 5.250

6.  Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A.

Authors:  Frank M Dyka; Sanford L Boye; Vince A Chiodo; William W Hauswirth; Shannon E Boye
Journal:  Hum Gene Ther Methods       Date:  2014-04       Impact factor: 2.396

Review 7.  Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.

Authors:  Kyle Chamberlain; Jalish Mahmud Riyad; Thomas Weber
Journal:  Hum Gene Ther Methods       Date:  2016-02       Impact factor: 2.396

Review 8.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

9.  Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.

Authors:  Bruce C Schnepp; Jeffrey D Chulay; Guo-Jie Ye; Terence R Flotte; Bruce C Trapnell; Philip R Johnson
Journal:  Hum Gene Ther       Date:  2016-01       Impact factor: 5.695

10.  Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors.

Authors:  F Curtis Hewitt; Chengwen Li; Steven J Gray; Shelley Cockrell; Michael Washburn; R Jude Samulski
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.